List of Studies ( Metabolite:Lentiginosine)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002759 | AN004479 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
| ST002759 | AN004481 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
| ST002760 | AN004483 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
| ST002760 | AN004485 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004489 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST003084 | AN005042 | Metabolic changes in embryonic CSF (Part 6) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003085 | AN005044 | Metabolome changes in embryonic CSF (Part 7) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003086 | AN005046 | Metabolome changes in embryonic CSF (Part 8) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003087 | AN005048 | Metabolome changes in embryonic CSF (Part 9) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | Blood | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | Liver | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003089 | AN005052 | Metabolome changes in embryonic CSF (Part 11) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003362 | AN005504 | Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide | Cultured cells | Human | Cancer | The Ohio State University | Counts |
| ST003362 | AN005506 | Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide | Cultured cells | Human | Cancer | The Ohio State University | Counts |
| ST001658 | AN002708 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | Peak area |
| ST003333 | AN005460 | Urine Metabolite Profiling in Indian Male Population at High Altitude using Liquid Chromatography – Mass Spectrometry: A Longitudinal Pilot Study | Urine | Human | Environmental exposure; Hypoxia | Defence Institute of Physiology and Allied Sceinces | Peak area |
| ST002698 | AN004372 | Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites | Infected Red Blood Cells | Plasmodium berghei | Malaria | Peter Doherty Institute for Infection and Immunity | peak height |
| ST000549 | AN000837 | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Blood | Mouse | Diabetes | Mayo Clinic | Peak intensity |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
